However, stimulator of IFN genes (STINGs)-induced IFN-β production by VEGFR2+ CD31+ TECs [77] or inhibition of PD-1 [77] or PD-L1 [57] reverses CD8+ T-cell dysfunction and promotes anti-tumour immune responses. Here, CD8A is linked to neoplasm.